Morgan Stanley’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.8M | Sell |
1,243,931
-113,539
| -8% | -$5.83M | ﹤0.01% | 2062 |
|
|
2026
Q1 | $80.5M | Buy |
1,357,470
+154,543
| +13% | +$10M | ﹤0.01% | 1629 |
|
|
2025
Q4 | $74.2M | Buy |
1,202,927
+71,078
| +6% | +$4.35M | ﹤0.01% | 1717 |
|
|
2025
Q3 | $70.6M | Buy |
1,131,849
+61,750
| +6% | +$4.3M | ﹤0.01% | 1711 |
|
|
2025
Q2 | $85.4M | Sell |
1,070,099
-161
| -0% | -$13.5K | 0.01% | 1445 |
|
|
2025
Q1 | $92M | Sell |
1,070,260
-15,533
| -1% | -$1.27M | 0.01% | 1309 |
|
|
2024
Q4 | $84.8M | Sell |
1,085,793
-34,346
| -3% | -$2.67M | 0.01% | 1378 |
|
|
2024
Q3 | $80.8M | Buy |
1,120,139
+191,767
| +21% | +$13.6M | 0.01% | 1405 |
|
|
2024
Q2 | $63.9M | Sell |
928,372
-141,417
| -13% | -$9.58M | ﹤0.01% | 1519 |
|
|
2024
Q1 | $77.6M | Buy |
1,069,789
+406,184
| +61% | +$27.2M | 0.01% | 1363 |
|
|
2023
Q4 | $40.6M | Sell |
663,605
-3,894
| -0.6% | -$231K | ﹤0.01% | 1945 |
|
|
2023
Q3 | $38.2M | Buy |
667,499
+51,831
| +8% | +$3.13M | ﹤0.01% | 1832 |
|
|
2023
Q2 | $36.6M | Sell |
615,668
-34,541
| -5% | -$2.07M | ﹤0.01% | 1880 |
|
|
2023
Q1 | $40.7M | Buy |
650,209
+4,410
| +0.7% | +$275K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $40.4M | Buy |
645,799
+19,491
| +3% | +$1.12M | ﹤0.01% | 1678 |
|
|
2022
Q3 | $31.2M | Sell |
626,308
-83,394
| -12% | -$4.62M | ﹤0.01% | 1729 |
|
|
2022
Q2 | $41.7M | Buy |
709,702
+448,087
| +171% | +$24.7M | 0.01% | 1524 |
|
|
2022
Q1 | $13.9M | Buy |
261,615
+14,700
| +6% | +$849K | ﹤0.01% | 2518 |
|
|
2021
Q4 | $15M | Sell |
246,915
-43,175
| -15% | -$2.56M | ﹤0.01% | 2483 |
|
|
2021
Q3 | $16.3M | Sell |
290,090
-649
| -0.2% | -$35.6K | ﹤0.01% | 2311 |
|
|
2021
Q2 | $15.1M | Sell |
290,739
-80,882
| -22% | -$3.88M | ﹤0.01% | 2492 |
|
|
2021
Q1 | $16.4M | Buy |
371,621
+159,636
| +75% | +$6.71M | ﹤0.01% | 2131 |
|
|
2020
Q4 | $7.39M | Buy |
211,985
+153,029
| +260% | +$5.43M | ﹤0.01% | 2839 |
|
|
2020
Q3 | $2.15M | Buy |
58,956
+8,162
| +16% | +$304K | ﹤0.01% | 3596 |
|
|
2020
Q2 | $1.91M | Buy |
50,794
+34,843
| +218% | +$1.39M | ﹤0.01% | 3643 |
|
|
2020
Q1 | $585K | Sell |
15,951
-84,734
| -84% | -$3.29M | ﹤0.01% | 4284 |
|
|
2019
Q4 | $4.08M | Buy |
100,685
+80,218
| +392% | +$2.99M | ﹤0.01% | 3422 |
|
|
2019
Q3 | $710K | Buy |
20,467
+10,239
| +100% | +$337K | ﹤0.01% | 4490 |
|
|
2019
Q2 | $324K | Sell |
10,228
-7,008
| -41% | -$208K | ﹤0.01% | 4817 |
|
|
2019
Q1 | $515K | Sell |
17,236
-80,086
| -82% | -$2.3M | ﹤0.01% | 4528 |
|
|
2018
Q4 | $3M | Sell |
97,322
-45,730
| -32% | -$1.67M | ﹤0.01% | 3429 |
|
|
2018
Q3 | $5.42M | Sell |
143,052
-31,931
| -18% | -$1.21M | ﹤0.01% | 3096 |
|
|
2018
Q2 | $6.72M | Sell |
174,983
-47,728
| -21% | -$1.61M | ﹤0.01% | 2816 |
|
|
2018
Q1 | $7.51M | Buy |
222,711
+18,171
| +9% | +$697K | ﹤0.01% | 2625 |
|
|
2017
Q4 | $9.08M | Sell |
204,540
-116,706
| -36% | -$5.32M | ﹤0.01% | 2493 |
|
|
2017
Q3 | $16.1M | Buy |
321,246
+186,517
| +138% | +$9.53M | ﹤0.01% | 1780 |
|
|
2017
Q2 | $7.12M | Sell |
134,729
-91,843
| -41% | -$4.92M | ﹤0.01% | 2489 |
|
|
2017
Q1 | $12.6M | Sell |
226,572
-18,499
| -8% | -$1.02M | ﹤0.01% | 1984 |
|
|
2016
Q4 | $12.8M | Sell |
245,071
-6,714
| -3% | -$324K | ﹤0.01% | 1997 |
|
|
2016
Q3 | $12.2M | Buy |
251,785
+39,087
| +18% | +$1.98M | ﹤0.01% | 1850 |
|
|
2016
Q2 | $11.8M | Sell |
212,698
-79,892
| -27% | -$4.4M | ﹤0.01% | 1845 |
|
|
2016
Q1 | $15.6M | Buy |
292,590
+22,093
| +8% | +$1.09M | 0.01% | 1502 |
|
|
2015
Q4 | $13.9M | Buy |
270,497
+141,853
| +110% | +$7.05M | 0.01% | 1706 |
|
|
2015
Q3 | $5.81M | Buy |
128,644
+35,865
| +39% | +$1.69M | ﹤0.01% | 2523 |
|
|
2015
Q2 | $4.29M | Buy |
92,779
+8,699
| +10% | +$381K | ﹤0.01% | 2930 |
|
|
2015
Q1 | $3.6M | Buy |
84,080
+4,404
| +6% | +$168K | ﹤0.01% | 3054 |
|
|
2014
Q4 | $2.77M | Buy |
79,676
+5,440
| +7% | +$181K | ﹤0.01% | 3270 |
|
|
2014
Q3 | $2.4M | Sell |
74,236
-17,608
| -19% | -$589K | ﹤0.01% | 3279 |
|
|
2014
Q2 | $3.11M | Sell |
91,844
-18,436
| -17% | -$591K | ﹤0.01% | 3117 |
|
|
2014
Q1 | $3M | Sell |
110,280
-41,423
| -27% | -$1.23M | ﹤0.01% | 3071 |
|
|
2013
Q4 | $5.43M | Sell |
151,703
-17,186
| -10% | -$571K | ﹤0.01% | 2491 |
|
|
2013
Q3 | $5.09M | Buy |
168,889
+67,900
| +67% | +$2.22M | ﹤0.01% | 2407 |
|
|
2013
Q2 | $2.94M | Buy |
+100,989
| New | +$2.85M | ﹤0.01% | 2826 |
|
Other funds holding PBH
AI
BIP
Morgan Stanley's PBH Position: Q2 2026 in Review
Morgan Stanley reduced its Prestige Consumer Healthcare (PBH) stake by 8.4% in Q2 2026, selling an estimated $5.83M and leaving 1,243,931 shares worth $58.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.
Morgan Stanley first reported a position in PBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $92M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Morgan Stanley held 1,243,931 shares of Prestige Consumer Healthcare worth $58.8M as of Q2 2026.
- Morgan Stanley sold 113,539 Prestige Consumer Healthcare shares in Q2 2026, an estimated $5.83M.
- Prestige Consumer Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2062 holding.
- Morgan Stanley first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Prestige Consumer Healthcare position peaked at $92M in Q1 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.